Louis Jacobson, PolitiFact

Trump Exaggerates Speed and Certainty of Prescription Drug Price Reductions

According to the timeline in the May 12 executive order, prescription drug price reductions would not happen “almost immediately,” but rather could take months or years. And extending the savings to Americans outside federal health insurance programs such as Medicare would likely require congressional action.

RFK Jr. Exaggerates Share of Autistic Population With Severe Limitations

HHS Secretary Robert F. Kennedy Jr. said this month that “autism destroys families,” adding that “most cases are now severe” and describing children who will never work, play baseball, write poetry, or go on a date. Medical experts and people on the autism spectrum say Kennedy’s portrayal was skewed.

In Montana Senate Race, Democrat Jon Tester Misleads on Republican Tim Sheehy’s Abortion Stance

Republican Senate candidate Tim Sheehy has said he supports letting states decide the abortion parameters within their borders and supports including exceptions for rape, incest, and the life of the pregnant woman in legislation to restrict abortion.

No, the Senate-Passed Reconciliation Bill Won’t Strip $300 Billion From Medicare

Under the Medicare drug negotiations provisions in the reconciliation bill, the federal government would see its outlays reduced by about $300 billion. That reduction wouldn’t result from cuts in benefits. Instead, Medicare would be empowered to leverage its market power to pay lower prices for certain drugs.

Guía para entender a las subvariantes de ómicron

¿Qué tan diferentes son estas subvariantes entre sí? ¿Puede la infección por una subvariante proteger a alguien de la infección por otra? Y, ¿qué tan bien funcionan contra estas variantes las vacunas que se desarrollaron antes de la aparición de ómicron?

Todo lo que hay que saber sobre omicron y las otras variantes del coronavirus

La variante omicron, conocida oficialmente como B.1.1.529, apareció en noviembre en varios países del sur de África. Las alarmas saltaron en todo el mundo cuando los funcionarios de salud pública de Sudáfrica vieron que empezaba a superar a delta, la cepa dominante hasta ahora.